The Calmer Co. Expands Global Growth Strategy with Strategic Manufacturing Partnership
The Calmer Co. International Limited (ASX: CCO) has signed a binding Heads of Agreement with Kaiming Agro Processing’s subsidiary, Pacific Culture and Heritage Pte. Ltd. (KAPPL), to establish a long-term manufacturing partnership. The collaboration is designed to strengthen production of kava, ginger and turmeric extracts by combining KAPPL’s advanced manufacturing capabilities with The Calmer Co.’s expertise in premium raw material sourcing, proprietary formulations, branded products and global commercialisation.
Under the proposed arrangement, The Calmer Co. will retain ownership of its intellectual property, brands, customer relationships and supply chain, while KAPPL will manufacture agreed botanical ingredients and consumer products. The partnership also supports the commissioning of a new advanced manufacturing facility in Fiji, expected in December 2026, enhancing production flexibility without significant capital investment. The phased agreement aims to expand manufacturing capacity, strengthen supply chain resilience and support long-term growth across global botanical ingredient and wellness markets.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
The Calmer Co. Expands Global Growth Strategy with Strategic Manufacturing Partnership
The Calmer Co. International Limited (ASX: CCO) has signed a binding Heads of Agreement with Kaiming Agro Processing’s subsidiary, Pacific Culture and Heritage Pte. Ltd. (KAPPL), to establish a long-term manufacturing partnership. The collaboration is designed to strengthen production of kava, ginger and turmeric extracts by combining KAPPL’s advanced manufacturing capabilities with The Calmer Co.’s expertise in premium raw material sourcing, proprietary formulations, branded products and global commercialisation.
Under the proposed arrangement, The Calmer Co. will retain ownership of its intellectual property, brands, customer relationships and supply chain, while KAPPL will manufacture agreed botanical ingredients and consumer products. The partnership also supports the commissioning of a new advanced manufacturing facility in Fiji, expected in December 2026, enhancing production flexibility without significant capital investment. The phased agreement aims to expand manufacturing capacity, strengthen supply chain resilience and support long-term growth across global botanical ingredient and wellness markets.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au